Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stacy J. Kanter Insider Profile
4 Followers
Stacy J. Kanter, Director at Applied Therapeutics, holds 3.00K shares in Oppenheimer Holdings (Ticker: OPY), holds 63.00K shares in Applied Therapeutics (Ticker: APLT).
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-20.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stacy J. Kanter holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stacy J. Kanter
Stacy J. Kanter's Trading History
Applied Therapeutics
Dec 05, 2023
Director
Informative Buy
65.10K
$279.72K
Oppenheimer Holdings
Jan 29, 2024
Director
Uninformative Buy
―
$121.65K
List of latest transactions for each holding click on a transaction to see Stacy J. Kanter's performance on stock
You May Also Like
Stacy J. Kanter insider profile FAQ
What is the percentage of profitable transactions made by Stacy J. Kanter?
The percentage of profitable transactions made by Stacy J. Kanter is 33%.
What is the average return per transaction made by Stacy J. Kanter?
The average return per transaction made by Stacy J. Kanter is -20.80%.
What stocks does Stacy J. Kanter hold?
Stacy J. Kanter holds: APLT, OPY stocks.
What was Stacy J. Kanter’s latest transaction?
Stacy J. Kanter latest transaction was an Uninformative Buy of ―.
What was Stacy J. Kanter's most profitable transaction?
Stacy J. Kanter’s most profitable transaction was an Informative Buy of APLT stock on December 5, 2023. The return on the trade was 86.80%.
What is Stacy J. Kanter's role in Applied Therapeutics?
Stacy J. Kanter's role in Applied Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.